PRCT PROCEPT BioRobotics Corp

Nasdaq procept-biorobotics.com


$ 35.90 $ -1.02 (-2.76 %)    

Wednesday, 29-Oct-2025 19:58:01 EDT
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 35.93
$ 36.87
$ 35.90 x 24
$ 37.50 x 3
$ 35.60 - $ 37.11
$ 32.11 - $ 103.81
1,583,413
na
2B
$ 1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-02-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 10-28-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 07-28-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-22-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-buy-on-procept-biorobotics-lowers-price-target-to-50

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price targe...

 btig-reiterates-neutral-on-procept-bioroboticsto-neutral

BTIG analyst Ryan Zimmerman reiterates PROCEPT BioRobotics (NASDAQ:PRCT) from Neutral to Neutral.

 oppenheimer-upgrades-procept-biorobotics-to-outperform-announces-60-price-target

Oppenheimer analyst Suraj Kalia upgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Perform to Outperform and announces $60 pric...

 wells-fargo-maintains-overweight-on-procept-biorobotics-lowers-price-target-to-58

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price targe...

 piper-sandler-maintains-overweight-on-procept-biorobotics-lowers-price-target-to-55

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price ta...

 procept-biorobotics-raises-fy2025-sales-guidance-from-323000m-to-325500m-vs-324423m-est

PROCEPT BioRobotics (NASDAQ:PRCT) raises FY2025 sales outlook from $323.000 million to $325.500 million vs $324.423 million est...

 procept-biorobotics-q2-eps-035-beats-041-estimate-sales-79182m-beat-75921m-estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $...

 procept-biorobotics-announces-preliminary-q2-revenue-of-792m

SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (NASDAQ:PRCT) ("the Company"), a surgical robot...

 procept-biorobotics-completes-three-prostate-cancer-procedures-in-water-iv-prostate-cancer-trial-in-asc-using-aquablation-therapy

PROCEPT BioRobotics® Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company dedicated to advancing pati...

 morgan-stanley-maintains-overweight-on-procept-biorobotics-lowers-price-target-to-68

Morgan Stanley analyst Patrick Wood maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price targe...

 oppenheimer-initiates-coverage-on-procept-biorobotics-with-perform-rating

Oppenheimer analyst Suraj Kalia initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Perform rating.

 b-of-a-securities-maintains-buy-on-procept-biorobotics-lowers-price-target-to-84

B of A Securities analyst Craig Bijou maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION